| Document and Entity Information - shares | 3 Months Ended | |
| Mar. 31, 2020 | May 12, 2020 | |
| Document And Entity Information | ||
| Entity Registrant Name | CANCER CAPITAL CORP | |
| Entity Central Index Key | 0001130889 | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2020 | |
| Entity Incorporation, State or Country Code | WY | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Entity File Number | 000-32363 | |
| Is Entity's Reporting Status Current? | Yes | |
| Entity Interactive Data Current | Yes | |
| Is Entity Emerging Growth Company? | true | |
| Elected Not To Use the Extended Transition Period | false | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Common Stock, Shares Outstanding | 6,150,000 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2020 | |
| Entity Shell Company | true |
| Condensed Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2020 | Dec. 31, 2019 |
| Current Assets | ||
| Cash | $ 3,703 | $ 218 |
| Total current assets | 3,703 | 218 |
| Total assets | 3,703 | 218 |
| Current Liabilities | ||
| Accounts payable - related party | 7,500 | 6,000 |
| Accounts payable | 2,400 | 1,200 |
| Notes payable - related party | 133,125 | 126,925 |
| Notes payable | 82,575 | 82,575 |
| Accrued interest - related party | 46,830 | 44,289 |
| Accrued interest | 42,466 | 40,815 |
| Total current liabilities | 314,896 | 301,804 |
| Total liabilities | 314,896 | 301,804 |
| STOCKHOLDERS' DEFICIT | ||
| Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding | 6,150 | 6,150 |
| Additional paid-in capital | 47,050 | 47,050 |
| Accumulated deficit | (364,393) | (354,786) |
| Stotal stockholders' deficit | (311,193) | (301,586) |
| Total liabilities and stockholders' deficit | $ 3,703 | $ 218 |
| Condensed Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2020 | Dec. 31, 2019 |
| Statement of Financial Position [Abstract] | ||
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock, authorized | 20,000,000 | 20,000,000 |
| Common stock, issued | 6,150,000 | 6,150,000 |
| Common stock, outstanding | 6,150,000 | 6,150,000 |
| Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
| Mar. 31, 2020 | Mar. 31, 2019 | |
| Income Statement [Abstract] | ||
| REVENUES | ||
| EXPENSES | ||
| General and administrative | 5,415 | 5,415 |
| Total expenses | 5,415 | 5,415 |
| Loss from operations before other expense | (5,415) | (5,415) |
| Other income (expense) non-operating | ||
| Interest expense - related party | (2,541) | (2,243) |
| Interest expense | (1,651) | (1,651) |
| Total other expense | (4,192) | (3,894) |
| Loss from operations before taxes | (9,607) | (9,309) |
| Taxes | ||
| Net loss | $ (9,607) | $ (9,309) |
| Net loss per share - Basic and diluted | $ 0 | $ 0 |
| Weighted average shares outstanding | 6,150,000 | 6,150,000 |
| Condensed Statement of Stockholders’ Deficit (Unaudited) - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
| Beginning balance, shares at Dec. 31, 2018 | 6,150,000 | |||
| Beginning balance, amount at Dec. 31, 2018 | $ 6,150 | $ 47,050 | $ (325,291) | $ (272,091) |
| Net (income) loss | (9,309) | (9,309) | ||
| Ending balance, shares at Mar. 31, 2019 | 6,150,000 | |||
| Ending balance, amount at Mar. 31, 2019 | $ 6,150 | 47,050 | (334,600) | (281,400) |
| Beginning balance, shares at Dec. 31, 2019 | 6,150,000 | |||
| Beginning balance, amount at Dec. 31, 2019 | $ 6,150 | 47,050 | (354,786) | (301,586) |
| Net (income) loss | (9,607) | (9,607) | ||
| Ending balance, shares at Mar. 31, 2020 | 6,150,000 | |||
| Ending balance, amount at Mar. 31, 2020 | $ 6,150 | $ 47,050 | $ (364,393) | $ (311,193) |
| Condensed Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
| Mar. 31, 2020 | Mar. 31, 2019 | |
| Cash Flows from Operating Activities | ||
| Net Loss | $ (9,607) | $ (9,309) |
| Adjustments to reconcile net loss to cash provided (used) by operating activities: | ||
| Expenses paid by related party | 1,500 | 1,500 |
| Changes in operating assets and liabilities: | ||
| Increase in accounts payable | 1,200 | 2,800 |
| Increase in accrued interest - related party | 2,541 | 2,243 |
| Increase in accrued interest | 1,651 | 1,651 |
| Net cash provided (used) by operating activities | (2,715) | (1,115) |
| Cash Flows from Investing Activities | ||
| Net cash provided by investing activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from notes payable - related party | 6,200 | 1,200 |
| Net cash provided by financing activities | 6,200 | 1,200 |
| Increase (decrease) in cash | 3,485 | 85 |
| Cash and cash equivalents at beginning of period | 218 | 168 |
| Cash and cash equivalents at end of period | 3,703 | 253 |
| Supplemental Cash Flow Information: | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Basis of Financial Statement Presentation | 3 Months Ended |
| Mar. 31, 2020 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Basis of Financial Statement Presentation | NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2019 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected for year ending December 31, 2020. |
| Going Concern | 3 Months Ended |
| Mar. 31, 2020 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| GOING CONCERN | NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies. The COVID-19 pandemic could have an impact on our ability to obtain financing to fund our operations. The Company is unable to predict the ultimate impact at this time. |
| Related Party Transactions | 3 Months Ended |
| Mar. 31, 2020 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | NOTE 3 – RELATED PARTY TRANSACTIONS During the three months ended March 31, 2020, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $1,500, resulting in the Company owing the shareholder $7,500 and $6,000 at March 31, 2020 and December 31, 2019, respectively. During the three months ended March 31, 2020, a shareholder loaned the Company $6,200. The notes bear interest at 8% and are due on demand. Notes payable – related party at March 31, 2020 and December 31, 2019 were $133,125 and $126,925, respectively. Accrued interest at March 31, 2020 and December 31, 2019 was $46,830 and $44,289, respectively. |
| Subsequent Events | 3 Months Ended |
| Mar. 31, 2020 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | NOTE 4 – SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements. |
| Related Party Transactions (Details Narrative) - USD ($) | 3 Months Ended | |
| Mar. 31, 2020 | Dec. 31, 2019 | |
| Related Party Transactions [Abstract] | ||
| Consulting, administrative and professional costs provided for or paid on behalf of Company by shareholder | $ 1,500 | |
| Amounts due to shareholder | 7,500 | $ 6,000 |
| Amounts loaned to Company by shareholder | 6,200 | |
| Notes payable - related party | 133,125 | 126,925 |
| Accrued interest on notes payable - related party | $ 46,830 | $ 44,289 |
| Interest rate on notes payable - related party | 8.00% |
